Onxeo SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Onxeo SA with three other
pharmaceutical manufacturers in Europe:
sales of 11.91 million Euro [US$14.74 million]
of which 100%
was Research & Development),
Swedencare AB (publ)
(85.49 million Swedish Kronor [US$10.17 million]
Biotec Pharmacon ASA
based in Norway
(66.69 million Norwegian Kroner [US$8.59 million]
Onxeo SA reported sales of 9.51 million Euro (US$11.76 million)
December of 2017.
increase of 114.9%
versus 2016, when the company's sales were 4.42 million Euro.